PUMA

academical publication management
collect, organize, and share publications

( en | de )

 

Disambiguation of "Merz, Maximilian"

Author of the publication

copydeleteadd this publication to your clipboard
A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation

, , , , , , , , , and . Genome Biology, (December 2023)
DOI: 10.1186/s13059-023-03120-7

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Merz, Maximilian
add a person with the name Merz, Maximilian
 

Other publications of authors with the same name

A digital twin model for evidence-based clinical decision support in multiple myeloma treatment, , , , , , , , , and 2 other author(s). Frontiers in Digital Health, (December 2023)Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma, , , , , , , , , and 23 other author(s). Nature Cancer, 5 (9): 1318–1333 (April 2024)A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation, , , , , , , , , and . Genome Biology, (December 2023)Predicting Progression Events in Multiple Myeloma from Routine Blood Work, , , , , , , and . Blood, 144 (Supplement 1): 7476–7476 (November 2024)Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma, , , , , , , , , and 19 other author(s). Leukemia, 38 (2): 372--382 (Feb 1, 2024)Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody, , , , , , , , , and 13 other author(s). Nature Medicine, 31 (4): 1145--1153 (Apr 1, 2025)Künstliche Intelligenz in der Entscheidungsunterstützung und medikamentösen Tumortherapie, , , , , , , and . Die Onkologie, 30 (5): 380–387 (February 2024)Teclistamab impairs detection of BCMA CAR-T cells, , , , , , , , , and 8 other author(s). Blood Advances, 7 (15): 3842–3845 (July 2023)Prognostic implications of splenomegaly in BCMA-directed CAR T-Cell therapy for relapsed myeloma, , , , , , , , , and 13 other author(s). Transplantation and Cellular Therapy, (July 2025)